期刊文献+

β连环素和表皮生长因子受体在非小细胞肺癌中表达的临床研究 被引量:1

The expression of β-catenin and epidermal growth factor receptor in non-small-cell lung cancer and its clinical significance
下载PDF
导出
摘要 目的:探讨β连环素和表皮生长因子受体在非小细胞肺癌中的表达及其临床意义。方法:采用免疫组化法回顾性研究了58例非小细胞肺癌标本β-catenin和EGFR的表达,并分析其表达与病理类型、分化程度和淋巴结转移的关系。结果:58例肺癌标本中β-catenin强阳性表达23例(36.66%);EGFR强阳性表达27例(46.55%),弱阳性表达19例(32.76%);β-catenin和EGFR的表达与病理类型均无关;β-catenin的表达与分化程度有关;β-catenin和EGFR的表达均与有无淋巴结转移密切相关;β-catenin与EGFR的表达呈负相关关系(r=-0.3317,P=0.0110)。结论:β-catenin与EGFR的表达与非小细胞肺癌的生长分化、淋巴转移等恶性行为密切相关,EGFR的高表达可能与β-catenin表达水平降低有关。 Objective: To investigate the expression of β-catenin and epidermal growth factor receptor in non-small-cell lung cancer and its clinical significance. Methods: The expression of β-catenin and epidermal growth factor receptor in 58 cases of non-small-cell lung cancer tissue sections were detected by immunohistochemistry. Correlations were investigated between fj-catenin and EGFR immunostaining in primary tumors and histological grade, lymph node stage.Results:23 of 58 cases showed strong β-catenin immunostaining and 27 of 58 cases showed strong EGFR immunostaining. β-catenin expression showed significant correlation with grades of differentiation. There were significant correlations between β-catenm and ECFR. expression and lymph node metastasis. Conclusion: The change of β-catenin and ECFR expression in surgically treated NSCLC are clearly associated with lymph node metastasis and histological grade.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2002年第7期513-514,516,共3页 Chinese Journal of Immunology
关键词 非小细胞肺癌 肺肿瘤 表皮生长因子受体 连环素 免疫组织化学 NSCLC 肿瘤浸润 肿瘤转移 Lung cancer Growth iactor receptor β-catenin Immunohistochemistry
  • 相关文献

参考文献3

二级参考文献6

  • 1余漫,国外医学.生理、病理科学与临床分册,1995年,15卷,99页
  • 2王效民,国外医学.肿瘤学分册,1994年,2卷,增刊,44页
  • 3顾兴华,国外医学.肿瘤学分册,1992年,19卷,98页
  • 4朱迅,国外医学.肿瘤学分册,1990年,6卷,325页
  • 5宋鸿钊,滋养细胞肿瘤的诊断与治疗,1981年,124页
  • 6王曦,李军.上皮钙粘附素-连环素复合体功能调控的研究进展[J].国外医学(分子生物学分册),1998,20(1):42-45. 被引量:11

共引文献8

同被引文献7

  • 1吴萍,张锦,李蓉,吕怀盛,秦憬,张建中.表皮生长因子受体EGFR和Ki67在非小细胞肺癌中的表达及其相关性研究[J].肿瘤防治杂志,2004,11(9):913-918. 被引量:7
  • 2Sxinivasan DM, Kapoor M, Kojima F,et al. Growth factor receptors: implications in tumor biology [ J]. Curr Opin lnvestig Drugs, 2005,6( 12 ) : 1246 - 1249.
  • 3Ji H, Li D, Chen L,et al. The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR - targeted therapies[J].Cancer Cell, 2006,9 ( 6 ) :485 - 495.
  • 4Ji H, Zhao X, Yuza Y,et al. Epidermal growth laetor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors[J].Proe Natl Aead Sci U S A, 2006,103 (20) :7817 -7822.
  • 5Lo HW, Hung MC. Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival [ J ]. Br J Cancer, 2006,94 ( 2 ) : 184 - 188.
  • 6Oliveira S, van Bergen en Henegouwen PM, Storm G,etal. Molecular biology of epidermal growth factor receptor inhibition for cancer therapy [ J ]. Expert Opin Binl Ther, 2006,6 ( 6 ) : 605 - 617.
  • 7Agelaki S, Georgoulias V. Epidermal growth factor receptor inhibitors in the treatment of non - small cell lung cancer[ J ]. J Neurosci ,2005,25 (48) : 11092 - 11106.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部